RECURSION PHARMACEUTICALS, INC. Peo Total Comp Amt
RECURSION PHARMACEUTICALS, INC. (RXRX) reported Peo Total Comp Amt of $9.61 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-30.
Financial Statements › Notes
ecd:PeoTotalCompAmt · last filed 2026-04-30
| Period end | Peo Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $9.61M DEF 14A · filed 2026-04-30 |
| 2024-12-31 | $8.50M DEF 14A · filed 2026-04-30 |
| 2023-12-31 | $8.61M DEF 14A · filed 2026-04-30 |
| 2022-12-31 | $6.32M DEF 14A · filed 2026-04-30 |
| 2021-12-31 | $673.59K DEF 14A · filed 2026-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |